Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Bashar Zeidan"'
Autor:
Bashar Zeidan, Antigoni Manousopoulou, Diana J. Garay-Baquero, Cory H. White, Samantha E. T. Larkin, Kathleen N. Potter, Theodoros I. Roumeliotis, Evangelia K. Papachristou, Ellen Copson, Ramsey I. Cutress, Stephen A. Beers, Diana Eccles, Paul A. Townsend, Spiros D. Garbis
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background Early-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored novel serum proteins as surrogate markers of progno
Externí odkaz:
https://doaj.org/article/186df17c7b314cb1a4df42f22cc12b09
Relationship between clinicopathological characteristics and margin involvement after SSM versus SIM
Autor:
Wilson Cheah, Sherif Rizkalla, Tatenda Nyoni, Victoria Beraud, Bashar Zeidan, Alison Luther, Ramsey Cutress
Publikováno v:
European Journal of Surgical Oncology. 49:e226
Autor:
Dick Rainsbury, Bashar Zeidan
Publikováno v:
Breast Cancer Essentials ISBN: 9783030731465
With the expansion of oncoplastic and reconstructive breast surgery, the complication and subsequent repercussions come at higher stakes. The identification and early management of early complications following breast surgery will ensure a faster and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc2cfee16e7fdc81e7f24a6d1b2dd7ae
https://doi.org/10.1007/978-3-030-73147-2_48
https://doi.org/10.1007/978-3-030-73147-2_48
Autor:
Bashar, Zeidan, Antigoni, Manousopoulou, Diana J, Garay-Baquero, Cory H, White, Samantha E T, Larkin, Kathleen N, Potter, Theodoros I, Roumeliotis, Evangelia K, Papachristou, Ellen, Copson, Ramsey I, Cutress, Stephen A, Beers, Diana, Eccles, Paul A, Townsend, Spiros D, Garbis
Publikováno v:
Breast Cancer Research : BCR
Background Early-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored novel serum proteins as surrogate markers of prognosis in pa
Publikováno v:
Breast (Edinburgh, Scotland). 29
Background In 2006 Nolvadex was discontinued and replaced by a variety of alternative generic tamoxifen brands for the adjuvant treatment of breast cancer. Anecdotally, patients are switching brands and taking alternative medications to reduce treatm
Autor:
J. O'Brien, A. Topps, C. Lee, David Westbroek, Gareth Irwin, M. Youssef, J. Ralph, T. Graja, Baek Kim, S. Hignett, D. Glassman, Smeer Kumar Aggarwal, Lucinda Frank, Steven Thrush, W. Hamilton-Burke, E.J.H. Turner, J. Parker, L. Ashken, H. Fatayer, J.B. Wild, S. Ledwidge, R. Rathinaezhil, K. McEvoy, S. Mansoor Khan, Mohammad A. Khan, Bashar Zeidan, S. Tang, J. Isherwood, Dennis Remoundos, Crosbie, Fayyaz Mazari, Kathryn Williams, Amarah Khan, D. Elfadl, Richard H. Hunt, Emma G MacInnes, N. Chand, W. Ismail, H. Tafazal, R.M. Jones, Tim Rattay, C. Kallaway, D. Cocker, S. Saha, Shelley Potter, C. Sirianni, H. Thomas, R. Foulkes, Ashvina Segaran, Elizabeth A. Baker, M.Q. Almerie, M. Venn, S. Bathla, F. Hoar, J. Singh, Charlotte Ives, Alison Waterworth, L. Jones, Richard J Johnson
Publikováno v:
The Mammary Fold Academic and Research Collaborative 2016, ' Variation in the management of ductal carcinoma in situ in the UK : Results of the Mammary Fold National Practice Survey ', European Journal of Surgical Oncology, vol. 42, no. 8, pp. 1153–1161 . https://doi.org/10.1016/j.ejso.2016.05.024
IntroductionDuctal carcinoma in situ (DCIS) accounts for approximately 10% of all newly-diagnosed breast cancers in the UK. The latest national guidelines were published in 2009 and may not reflect current best practice. We aimed to explore variation
Autor:
Bashar Zeidan, Lorenzo Bernaudo, Sophie Helme, Constantinos Yiangou, Lucy Mansfield, Avi Agrawal
Publikováno v:
European Journal of Surgical Oncology. 44:903
Autor:
Paul A. Townsend, Diana J. Garay-Baquero, Samantha E.T. Larkin, Kathleen N. Potter, Antigoni Manousopoulou, Bashar Zeidan, Evangelia K. Papachristou, Ramsey I. Cutress, Stephen A. Beers, Cory H. White, Diana Eccles, Theodoros I. Roumeliotis, Ellen Copson, Spiros D. Garbis
Publikováno v:
European Journal of Surgical Oncology. 44:905
Autor:
Nikolaos Marikakis, Lorenzo Bernaudo, Lucy Mansfield, Avi Agrawal, Constantinos Yiangou, Bashar Zeidan, Sophie Helme
Publikováno v:
European Journal of Surgical Oncology. 44:901
Autor:
Alex H. Mirnezami, Claire Hastie, Graham Packham, Bashar Zeidan, Ramsey I. Cutress, Paul A. Townsend
Publikováno v:
Clinical Proteomics. 5:133-147
Background Proteomic profiling is a rapidly developing technology that may enable early disease screening and diagnosis. Surface-enhanced laser desorption ionization–time of flight mass spectrometry (SELDI-TOF MS) has demonstrated promising results